Content of the study

Available languages


1.1 Definition and scope of study

The pharmaceutical industry encompasses the development, production and marketing of medicine. North America has the largest global market in terms of revenue, mainly as a consequence of the historical role of the American industry. However, the Chinese pharmaceutical sector has recently shown the highest growth rates. Nevertheless, the main pharmaceutical companies come from the United States (Pfizer, Johnson & Johnson, AbbVie) and Europe (Novartis, Roche, GlaxoSmithKline, AstraZeneca, Sanofi).

Most of the income of these companies is from patented drugs, in which oncology is the main prescription-based therapeutic class. Not coincidentally, many players in the pharmaceutical sector invest 20% or more of their revenues in the research and development (R&D) segment. This participation may be significantly higher in small companies specializing in research. The United States is a traditional stronghold of pharmaceutical innovation and most new substances introduced to the market originate in the United States. Due to the constant loss of patent protection, the invention of new drugs is of utmost importance for the industry, as the expiry of patents leads to significant financial losses.

Brazil has become a major attraction for investors in the industry and the pharmaceutical market as a whole. The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023, supported by the growing access of the population to medical services and products. In addition, the country is the 6th largest pharmaceutical market in the world, behind only the United States, China, Japan, Germany and France. The sector is expected to continue growing. With Brazilian currency increasingly devalued, a competitive environment in expansion and international companies focused on innovative medicine, it leaves room for national competitors to operate in the segment of already mature products.






To keep reading, buy the full research

What is in this market study?

  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What are the latest trends in this market?
  • What is the positioning of companies in the value chain?
  • How do companies in the market differ from each other?
  • Access company mapping and profiles.
  • Data from several dozen databases

  • This market study is available online and in pdf format (30 p.)
  • Consult an example PDF or online
Buy this market study 89€

Availability within 10 business days


Analysts 1 sector analyzed
in 40 pages


  • Top Universities
  • Expert opinion


  • Databases
  • Press
  • Company reports


  • Continuously updated
  • Permanent watch


  • Synthetic structure
  • Standardized charts

Reviews (3)

The Insulin Pump Market - France

Publicado en 11/01/2022 by Amaury Wernert

A very precise and detailed study of this market, driven by the strong growth of this disease in the world

Businesscoot Response:

Hello Amaury, Thank you for your feedback. We are happy to read that the content of the study has fully met your expectations. :)

The dental implant market - France

Publicado en 07/01/2022 by Denis Monnoyeur

The study highlights three trends: the dynamism of the market, the concentration of players and the practice of high prices.

Businesscoot Response:

Hello Denis, Thank you very much for this very positive review! We are delighted to see that you appreciate our studies and we thank you for the trust you have placed in us.

The Parapharmacy Market - France

Publicado en 07/01/2022 by Client anonyme - Ce client a souhaité rester anonyme

Clear and concise generic study. Well documented. However, I would have liked to see that the actors' files at the end of the report corresponded precisely to those stated in the report.

Businesscoot Response:

Hello, Thank you for your feedback on our study. We are planning to update it taking into account your remarks, we will keep you informed as soon as it is available.